Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
144.38
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
94
95
Next >
Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On
October 09, 2023
Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.
Via
The Motley Fool
Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8
October 08, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Oct. 2-6.
Via
Talk Markets
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.
Via
InvestorPlace
My Top Under-Appreciated Dividend King to Buy in October
October 08, 2023
This company is putting on a clinic on how to operate as a successful industrial conglomerate.
Via
The Motley Fool
Johnson & Johnson Dividend Stock Analysis
October 06, 2023
Johnson & Johnson is a leader in the pharmaceutical, medical device, and consumer products industries.
Via
Talk Markets
Expert Ratings for Johnson & Johnson
October 05, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 05, 2023
Via
Benzinga
Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst
October 05, 2023
Shares of Johnson & Johnson (NYSE: JNJ) recovered slightly in early trading on Thursday, after tanking in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
3 Ways AI Can Help Healthcare Companies Grow
October 05, 2023
The hottest AI stocks are in tech right now, but the best opportunities ahead may be in healthcare.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Magnificent Dividend Kings to Buy Now
October 05, 2023
These stocks offer you income no matter what the market is doing.
Via
The Motley Fool
3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October
October 05, 2023
These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
7 Top Healthcare Stocks That Pay Dividends
October 04, 2023
With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends.
Via
InvestorPlace
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories
October 04, 2023
Benzinga
Via
Benzinga
Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims
October 04, 2023
A New Jersey appeals court overturned a $223.8 million verdict linked to asbestos exposure in Johnson & Johnson's (NYSE: JNJ)
Via
Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Benzinga
Via
Benzinga
Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say
October 03, 2023
Discover how Goldman Sachs analysts analyze S&P 500 ROE in light of rising interest rates and the AI revolution. Consider these stock picks.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine
October 03, 2023
Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and commercialize the vaccine candidate for extraintestinal&nb
Via
Benzinga
Johnson & Johnson Urged To Expand Access Tuberculosis Medication
October 02, 2023
Global health aid agency Unitaid is advocating for expanded access to tuberculosis (TB) drug, bedaquiline, produced by Johnson & Johnson (NYSE: JNJ).
Via
Benzinga
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
October 01, 2023
Kenvue says rewarding shareholders is an important part of its strategy.
Via
The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
September 30, 2023
Its valuation depends on its brands being highly valuable indefinitely.
Via
The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
These stocks come with great dividends and more.
Via
The Motley Fool
Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times
September 29, 2023
Are you looking to invest in recession-proof stocks? Here are three stocks that thrive in tough economic times.
Via
InvestorPlace
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
September 29, 2023
Dividend stocks have proven themselves over time to outperform non-paying stocks so it's smart to buy them when they go on sale.
Via
InvestorPlace
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
September 29, 2023
Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
September 28, 2023
AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiation
Via
Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an
Via
Benzinga
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
The company may have best-in-class autoimmune disease therapy under its roof.
Via
The Motley Fool
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
94
95
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.